PRE-CLINICAL DRUG DEVELOPMENT - RATIONALE AND METHODS

被引：0
|
作者：
VENDITTI, JM [1 ]
机构：
[1] NCI,DIV CANC TREATMENT,PROGRAM DEV THERAPEUT,DRUG EVALUAT BRANCH,BETHESDA,MD 20205
来源：
SEMINARS IN ONCOLOGY | 1981年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：349 / 361
页数：13
相关论文
共 50 条
  • [31] Biopsychosocial influence on shoulder pain: Rationale and protocol for a pre-clinical trial
    George, Steven Z.
    Staud, Roland
    Borsa, Paul A.
    Wu, Samuel S.
    Wallace, Margaret R.
    Greenfield, Warren H.
    Mackie, Lauren N.
    Fillingim, Roger B.
    CONTEMPORARY CLINICAL TRIALS, 2017, 56 : 9 - 17
  • [32] Polyphenols in the prevention and treatment of sepsis syndromes: Rationale and pre-clinical evidence
    Shapiro, Haim
    Lev, Shaul
    Cohen, Jonathan
    Singer, Pierre
    NUTRITION, 2009, 25 (10) : 981 - 997
  • [33] Sulfamates in drug design and discovery: Pre-clinical and clinical investigations
    Zaraei, Seyed-Omar
    Abduelkarem, Abduelmula R.
    Anbar, Hanan S.
    Kobeissi, Sara
    Mohammad, Miami
    Ossama, Aya
    El-Gamal, Mohammed I.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 179 : 257 - 271
  • [34] TEM8 in Oncogenesis: Protein Biology, Pre-Clinical Agents, and Clinical Rationale
    Kareff, Samuel A.
    Corbett, Virginia
    Hallenbeck, Paul
    Chauhan, Aman
    CELLS, 2023, 12 (22)
  • [35] Ferric chloride-induced arterial thrombosis model in pre-clinical drug development
    Neves, L. A. A.
    Tiniakova, O.
    Wang, H.
    Huang, J.
    Senese, P. B.
    Gralinski, M. R.
    Hock, F. J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S30 - S30
  • [36] PRE-CLINICAL DEVELOPMENT OF CGM-CKM
    Tamir, I.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A8 - A9
  • [37] Ferric Chloride-Induced Arterial Thrombosis Model in Pre-Clinical Drug Development
    Neves, Liomar
    Tiniakova, Olga
    Wang, Hongjian
    Huang, Jinbao
    Senese, Peter
    Gralinski, Michael
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2017, 88 : 218 - 218
  • [38] Pre-clinical toxicology considerations for vaccine development
    Al-Humadi, Nabil
    VACCINE, 2017, 35 (43) : 5762 - 5767
  • [39] Development and Application of a Pre-Clinical Stereotactic Irradiator
    Solberg, T.
    Pidikiti, R.
    Song, K.
    Speiser, M.
    Stojadinovic, S.
    Saha, D.
    Seliounine, S.
    MEDICAL PHYSICS, 2009, 36 (06)
  • [40] Tight binding enantiomers of pre-clinical drug candidates
    Evans, Gary B.
    Cameron, Scott A.
    Luxenburger, Andreas
    Guan, Rong
    Suarez, Javier
    Thomas, Keisha
    Schramm, Vern L.
    Tyler, Peter C.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (17) : 5326 - 5333
12345